Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study

Title
Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study
Authors
Keywords
Cost-effectiveness, Economic evaluation, Hepatitis c virus, Boceprevir
Journal
BMC INFECTIOUS DISEASES
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-04-27
DOI
10.1186/1471-2334-13-190

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More